News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Kristina Jankovic: Intratumoral Pembrolizumab and mRNA-2752 for High-Risk DCIS
Kristina Jankovic/X
Jan 21, 2025, 09:58

Kristina Jankovic: Intratumoral Pembrolizumab and mRNA-2752 for High-Risk DCIS

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, posted the following on X:

“Intratumoral pembrolizumab and mRNA-2752 for high-risk DCIS: Phase 1 nonrandomized trial

  • 80% response rate
  • No major systemic toxicities
  • Complete tumor resolution in some cases, possibly reducing surgery

Ongoing studies are needed.”

Kristina Jankovic: Intratumoral Pembrolizumab and mRNA-2752 for High-Risk DCIS

cancer clinical trial DCIS high-risk breast cancer Kristina Jankovic mRNA-2752 OncoDaily Oncology pembrolizumab tumor response
Special Coverage
Blog
Feb 22, 2025, 04:42
Jessica Schubel: I'm launching my very own health care and aging policy consulting firm - Day One Strategies
Blog
Feb 22, 2025, 04:37
Karen Knudsen: Honored to be part of the Moffitt Cancer Center External Advisory Committee
Blog
Feb 22, 2025, 04:33
SPCC announced the upcoming launch of the "Digital Oncology" book series
Blog
Feb 22, 2025, 04:29
Results from the SIOPE OCEAN project are out
Blog
Feb 22, 2025, 04:25
Empower families to face their cancer journey with strength and hope - Cancer Hope Network
Blog
Feb 22, 2025, 04:19
Secure your spot for the CCI4EU Online Course by ESO
Blog
Feb 22, 2025, 04:16
Manchester Cancer Research Centre will continue its leadership in early detection science following the renewal of ACED
Blog
Feb 22, 2025, 04:12
Citrus Oncology is part of the 14 startups selected for the 2025 CancerX Accelerator
Science
Feb 22, 2025, 04:08
Anticancer potential of NO-Donor Oxadiazole in malignant pleural mesothelioma - The Babak Lab
Blog
Feb 22, 2025, 03:56
Early bird registration deadline for the 15th CCI Europe Conference approaches
Blog
Feb 22, 2025, 03:52
Share Your MASCC Guidelines Experience
Insight
Feb 22, 2025, 03:44
George Vlachogiannis: Cutting cancer mortality in Canada by 50% by 2050 - can we get there?